Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Details |
| Amoxetine HA1405-3014 | C15H18ClNO2S2 | 494221-37-3 | Details |
| Dibemethine | C15H17N | 102-05-6 | Details |
| N-Benzylidenemethanamine | C8H9N | 622-29-7 | Details |
| Trazodone Impurity INT3-A | C13H18BrClN2 | 142944-48-7 | Details |
| Ruxolitinib INT1-A | C8H13NO | 1000538-32-8 | Details |
| 3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | C11H14BrN3 | 1822969-98-1 | Details |
| Ruxolitinib Impurity B | C16H18N6O | 2606144-45-8 | Details |
| Diphenymethylpiperazinylethanol | C19H26Cl2N2O | 108983-83-1 | Details |
| Putomanib Impurity 10 | C14H12F3N3O5 | 1131004-99-3 | Details |
| Putomanib Impurity 9 | C15H14F3N3O5 | 2151045-16-6 | Details |
| 4-Nitroaniline | C6H6N2O2 | 100-01-6 | Details |
| 4-NITROBENZENESULFONIC ACID | C6H5NO5S | 138-42-1 | Details |
| Ethyl (2-bromophenyl)acetate | C10H11BrO2 | 2178-24-7 | Details |
| Ethyl 4-bromobenzoate | C9H9BrO2 | 5798-75-4 | Details |
| Ethyl 3-Bromophenylacetate | C10H11BrO2 | 14062-30-7 | Details |
| 3,4-Diethoxyaniline | C10H15NO2 | 39052-12-5 | Details |
| Dapagliflozin Impurity | C30H28Cl2O2 | 2176485-21-3 | Details |
| Etoposide EP Impurity H | C23H24O8 | 102306-95-6 | Details |
| Indacaterol maleate S-isomer | C24H28N2O3 | 1235445-80-3 | Details |
| Indacaterol maleate impurity 527-00 | C24H30N2O3 | 1403389-05-8 | Details |
| Cleviprex Impurity 2 | C15H13Cl2NO2 | 105383-68-4 | Details |
| 3-Phenothiazone | C12H7NOS | 581-30-6 | Details |
| 2-Bromo-N-propylacetamide | C5H10BrNO | 5395-67-5 | Details |
| ethyl 1-nitrosopiperidine-4-carboxylate | C8H14N2O3 | 160114-74-9 | Details |
| Single bond impurities 70 | C13H16ClNO2 | 1147995-98-9 | Details |
| 4-(pyridine-3-yl)-1,2,5-thiodiazepinepentocyclopento-3-phenol | Details |
| HPS2-C | Details |
| Letermovir impurity INT3-F racemate hydrochloride | Details |
| Impurity V(YD-Z3) | Details |
| salbutaMol sulphate iMpurity F | C13H23NO7S | Details |
| Tegoprazan LXI-15028-11 | Details |
| C19H25F3N2O6 | Details |
| Details |
| Cadoxetate Disodium[mpurity 5 | Details |
| C15H17NO2S2 | 763079-11-4 | Details |
| C15H15N | 92850-02-7 | Details |
| Details |
| C28H34BN5O5 | 1194235-41-0 | Details |
| C11H16O2 | 61102-09-8 | Details |
| Details |
| Bradyneo impurity 12 | Details |
| (6R,7S)-Ceftriaxone | Details |
| Rivaroxaban Impurity 17 | C5H4O2S | 527-72-0 | Details |
| Safinamide Mesyalte | C17H19FN2O2.CH4O3S | 202825-46-5 | Details |
| (5-broMo-2-chlorophenyl)(4-hydroxyphenyl)Methanone | C13H8BrClO2 | 1360568-68-8 | Details |
| Blonanserin Impurity INT2 | C17H17ClFN | 132813-14-0 | Details |
| JTJ-1-4 | C9H14O3 | 610-89-9 | Details |
| Deferasirox Impurity D | C21H15N3O4 | 2254105-61-6 | Details |
| N-Ethyl-2,3-dioxopiperazine | C6H10N2O2 | 59702-31-7 | Details |
| Decarboxy Gatifloxacin | C18H22FN3O2 | 1029364-59-7 | Details |
| linezolid impurity R | C12H15FN2O3 | 212325-40-1 | Details |
| JTJ-1-5 | C7H8O2 | 675-09-2 | Details |
| Linoleyl alcohol | C18H34O | 506-43-4 | Details |
| YD201-Z2 | C12H17NO2 | 57960-84-6 | Details |
| Bilastine impurity F （Bilastine impurity 09） | C13H17ClO2 | 1181267-33-3 | Details |
| Morinidazole Impurity 8 | C11H18N4O5 | 1413431-46-5 | Details |
| Etoricoxib Impurity H | C25H20ClN3O3S | 1817735-82-2 | Details |
| 1-Nonadecanol | C19H40O | 1454-84-8 | Details |
| Linoleol | C18H32O | 24149-05-1 | Details |
| 1’-Hydroxy Bilastine（Bilastine impurity 19） | C28H37N3O4 | 1638785-23-5 | Details |
| Isocaffeine | C8H10N4O2 | 519-32-4 | Details |
| Imp.D | C10H14N4O3 | 59413-14-8 | Details |
| BeclomethasoneDipropionateImpurityD | C28H37BrO7 | 52092-14-5 | Details |
| Imp.L | C12H20N4O2 | 70486-28-1 | Details |
| HPS2-D | C23H28O7 | 3949-79-9 | Details |
| C23H39NO2 | 2839928-15-1 | Details |
| Bepidorate intermediate impurity 1 | Details |
| Deferasirox Methyl Ester | C22H17N3O4 | 1266741-05-2 | Details |
| BNDP103 | C12H18ClNO | 105973-51-1 | Details |
| 3-(1-Methylcyclobutyl)prop-2-enenitrile | 2154505-00-5 | Details |
| Etratimod impurity | Details |
| SHFI018-Z3 | Details |
| Itramod arginine impurity IV-5 | Details |
| 4-Pentenoic acid,2-acetyl-2-(2-propen-1-yl)-, methyl ester | C11H16O3 | 3666-84-0 | Details |
| Ipratropium Bromide EP Impurity F | C20H28BrNO2 | 60018-35-1 | Details |
| Methyl2-acetyl-4-pentenoate | C8H12O3 | 003897-04-9 | Details |
| CMS203 Impurity 4 | Details |
| Ornithine aspartate impurity 12 | Details |
| LXI-15028-11 | Details |
| Details |
| Aprocitentan Impurity D | Details |
| Blonanserin Impurity L | C24H33N3O | 132810-93-6 | Details |
| Bepidoic acid intermediate I monohydrolyzed impurities | Details |
| Etratimod arginine impurity IV-1 | Details |
| C13H18O8 | 334948-52-6 | Details |
| JTJ-1-3 | C7H10O3 | 5399-21-3 | Details |
| Rosuvastatin Calcium Impurity G Control (Enantiomer) | Details |
| JTJ-2-3 | C8H16O2 | 408326-39-6 | Details |
| N-Nitroso-Meglumine | C7H16N2O6 | 62137-31-9 | Details |
| 3-(4-Methoxy-1,2,5-thiadiazol-3-yl)pyridine | C8H7N3OS | 131987-61-6 | Details |
| Dabigatran etexilate mesylate intermediate II impurity 11 | Details |
| Sulfamic Acid Impurity 29 | C17H19FN2O3 | 2270245-27-5 | Details |
| (1r,4r)-4-(6,8-dibromo-1-nitroso-1,4-dihydroquinazoline-3(2H)-yl)cyclohexane-1-ol | Details |
| N-(2-(4-amino-3,5-dichlorophenyl)-2-hydroxyethyl)-N-(tert-butyl)nitrosamidite | Details |
| N-(2-amino-3,5-dibromobenzyl)-N-((1s,4s)-4-hydroxycyclohexyl)nitrosamidite | Details |
| (R)-(1-(benzylamino)-3-methoxy-1-oxopropyl-2-yl)propyl carbamate | Details |
| Cefoxitin Impurity A | C15H16N2O6S2 | 54333-94-7 | Details |
| Aprocitentan Impurity II-3 | Details |
| 1,3-Bis(4-phenylbutyric acid)-2-hydroxypropanediester | C23H28O5 | 864811-35-8 | Details |
| Product Total： Product Page： | ||||
| 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 | ||||